Antonio Fernández‐Nebro

Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

Ricard Cervera, Jean‐Charles Piette, Josep Font et al. · Arthritis & Rheumatism · 2002 · 2.2K citations · Full text

Life Sciences, Hematology, Immunology +15

Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period

Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine · 2003 · 1.4K citations · Full text

Medicine, Nephrology, Autoimmunity +10

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Ricard Cervera, Rosa Serrano, Guillermo Pons‐Estel et al. · Annals of the Rheumatic Diseases · 2014 · 962 citations · Full text

Medicine, Hematology, Clinical Epidemiology +16

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients

Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine · 1999 · 432 citations

Medicine, Clinical Sciences, Internal Medicine +9